Postoperative adjuvant therapy for resectable early non-small cell lung cancer: A protocol for a systematic review and meta-analysis

BACKGROUND: Lung cancer is one of the most common malignant tumors, and non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer diagnosed. For patients with resectable early stage non-small cell lung cancer, routine postoperative adjuvant therapy can significantly prolong overall pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Chai, Tianci, Zhang, Peipei, Lin, Yuhan, Zhang, Zhenyang, Lin, Wenwei, Kang, Mingqiang, Lin, Jiangbo
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6709161/
https://ncbi.nlm.nih.gov/pubmed/31348250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016468
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars